查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610888

自動體外去顫器(AED)的全球市場 - 市場考察，競爭情形，市場預測(2030年)

Automated External Defibrillator (AED) - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計 2024 年至 2030 年預測期內，全球自動體外心臟去顫器 (AED) 市場規模將以 8.62% 的複合年增長率成長。該市場呈現顯著的市場成長，主要是由於患有心血管疾病（包括心房顫動和冠狀動脈疾病（CAD））等慢性疾病的患者數量不斷增加、主要參與者的創新產品開發活動以及老年人口的增加。

自動體外心臟去顫器 (AED) 市場動態

根據《世界心臟報告（2023）》提供的數據，到2021年，全球將有超過5億人患有心血管疾病。此外，根據美國心臟協會（2023）提供的最新數據，預計到2030年，全球將有超過1,200萬人受到心房顫動的影響。根據英國心臟基金會的全球心臟和循環系統疾病情況說明書（2024 年），目前全球約有 2 億人患有 CAD。

自動體外心臟去顫器 (AED) 對於治療心血管疾病和心房顫動和 CAD 等病症至關重要。自動體外心臟去顫器 (AED) 可以提供電擊，使心臟驟停的人恢復正常心律。如果您患有心房顫動，導致您的心律不規則，您可以使用它來將您的心律重置為正常。如果 CAD 導致心臟驟停，這些設備可以幫助挽救生命。它的使用有助於透過提供及時幹預並增加關鍵時刻成功復甦的可能性來提高生存率。

全球監管機構增加的產品開發活動預計也將面臨自動體外心臟去顫器 (AED) 市場的成長。例如，2024 年1 月，Element Science 推出了一款貼片去除產品，旨在為有心臟驟停風險且無法或不願意長期植入的人提供更可穿戴的選擇。年獲得了CE 標誌。

根據世界衛生組織（WHO）2021年發布的數據，從2015年到2050年，60歲及以上人口數量將翻一番，從12%增至22%，到2050年將達到21億人。此外，到 2030 年，六分之一的人將年齡在 60 歲或以上。隨著世界人口老化，60歲以上更容易罹患心臟病的人數顯著增加，自動體外心臟去顫器（AED）在緊急醫療救護中發揮重要作用。自動體外心臟去顫器（AED）用於在心臟驟停時恢復正常心律，由於與年齡相關的健康狀況，這種情況在老年人中更為常見。立即挽救生命的干預措施可以顯著提高老年人的生存率和預後，使其成為老化社會緊急系統的重要組成部分。

因此，上述所有因素共同推動了整個自動體外去顫器 (AED) 市場的成長。

然而，自動體外心臟去顫器（AED）引起的電擊（涉及電極部位燒傷和皮膚損傷）可能對自動體外去顫器（AED）市場的成長構成課題。

本報告提供全球自動體外去顫器(AED)市場相關調查分析，提供各地區市場規模與預測，過去3年的產品/技術開發，市場主要企業，未來的機會等資訊。

目錄

第1章 自動體外去顫器(AED)市場報告的簡介

第2章 自動體外去顫器(AED)市場摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 自動體外去顫器(AED)市場主要原因的分析

  • 自動體外去顫器(AED)市場促進因素
    • 心血管疾病增加
    • 增加產品開發活動
    • 與生活方式相關的疾病增加
    • 老年人口增加
  • 自動體外心臟去顫器 (AED) 市場的限制與課題
    • 自動體外心臟去顫器 (AED) 造成的電擊，電極部位有燒傷或皮膚損傷
  • 自動體外心臟去顫器 (AED) 市場機會
    • 與遠距醫療平台和遠端監控系統等數位健康解決方案集成
    • 人工智慧和機器學習的應用與更準確的診斷相關

第6章 自動體外去顫器(AED)市場波特的五力分析

第7章 自動體外去顫器(AED)市場評估

  • 各產品類型
    • 穿戴式
    • 非穿戴式
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 居家照護環境
    • 其他
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 自動體外去顫器(AED)市場企業與產品的簡介

  • Koninklijke Philips N.V.
  • ZOLL Medical Corporation
  • BPL Medical Technologies
  • Stryker
  • Mediana Co., Ltd
  • CU Medical System Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • SCHILLER
  • Bexen Cardio PLC.
  • Nihon Kohden Corporation
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Progetti S.r.l.
  • Abbott
  • HEARTHERO
  • Kestra Medical Technologies, Inc.
  • Trivitron Healthcare
  • F. Amiitalia
  • Shanghai Huifeng Medical Instrument Co., Ltd
  • Metrax GmbH
  • Meditech Equipment Co ., Ltd

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明，諮詢方式

Product Code: DIMDCL0467

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of cardiovascular disorders and the rising product developmental activities worldwide

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030. The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

Automated External Defibrillators Market Dynamics:

As per data provided by the World Heart Report (2023), in 2021 it was stated that more than half a billion people were living with cardiovascular diseases globally. Further, according to the updated data provided by the American Heart Association (2023), it is estimated that by 2030 over 12 million people will have atrial fibrillation globally. According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world.

Automated external defibrillators are crucial in managing cardiovascular diseases and conditions like atrial fibrillation and CAD. For individuals experiencing sudden cardiac arrest, automated external defibrillators can deliver an electric shock to restore a normal heart rhythm, which is vital in emergencies. In cases of atrial fibrillation, where the heart's rhythm becomes irregular, these can be used to reset the heart's rhythm to its normal state. These devices can be life-saving in instances where CAD leads to cardiac arrest. Their use helps improve survival rates by providing timely intervention and increasing the chances of successful resuscitation during critical moments.

Increased product developmental activities by regulatory bodies worldwide is also slated to witness market growth for automated external defibrillators. For example, in January 2024, Element Science received a CE mark in Europe and approval in the U.K. for its patch-based cardioverter defibrillator, designed to offer a more wearable option for individuals at risk of sudden cardiac arrest who may not qualify for or prefer not to have a long-term implant.

As per data provided by the World Health Organization 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. As the global population ages, with a significant increase in individuals over 60 years old, who are more susceptible to cardiac events, automated external defibrillators play a vital role in emergency medical care. They are used to restore normal heart rhythms in cases of sudden cardiac arrest, which is more common in older adults due to age-related health conditions. By providing immediate, life-saving intervention, these can significantly improve survival rates and outcomes for the elderly, making them an essential component of emergency response systems in aging societies.

Therefore, all the factors stated above collectively will drive the overall automated external defibrillator market growth.

However, electric shock delivered by automated external defibrillators associated with burns or skin damage at the electrode site, and others may prove to be challenging factors for the automated external defibrillators market growth.

Automated External Defibrillators Market Segment Analysis:

Automated External Defibrillators Market by Product Type (Wearable and Non-Wearable), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of automated external defibrillators, the wearable category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and various key features of wearable defibrillators that enhance their utility and effectiveness.

Wearable automated external defibrillators have gained widespread use as a critical safety measure for individuals at high risk of sudden cardiac arrest, particularly those who may not yet qualify for an implantable defibrillator or are awaiting surgery. Key features of these devices include real-time heart monitoring, which provides continuous surveillance without requiring any action from the user. They are equipped with voice and visual prompts that guide the user or bystanders through the defibrillation process, ensuring that the device is easy to operate even in high-stress situations. Also, these devices are designed to be lightweight and comfortable, allowing patients to go about their daily activities with minimal disruption.

Furthermore, technological advancements and product innovations taking place in the development of wearable automated external defibrillators are likely to propel the automated external defibrillators market growth. For instance, in August 2021, Kestra(TM) Medical Technologies, Inc. announced that the company received premarket approval from the U.S. Food and Drug Administration (FDA) for the ASSURE(R) Wearable Cardioverter Defibrillator system.

Therefore, the widespread uses and various key features of wearable defibrillators that enhance performance and usability are solidifying the impact on the growth of the overall automated external defibrillators market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall automated external defibrillators market:

Among all the regions, North America is expected to dominate the automated external defibrillators market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.

As per data provided by the National Institute of Health (2023), it stated that 20.5 million people in the US were living with CAD. Furthermore, according to data from the Centers for Disease Control and Prevention (2024), it was stated that 805,000 people in the US have a myocardial infarction (heart attack) every year on average. Furthermore, as per the same source, it was stated that heart disease is an umbrella term that encompasses numerous indications such as acute coronary syndrome, atherosclerosis, and congestive heart failure among others. Some of the key risk factors associated with heart disease are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Data from the Canadian Institute for Health Information (2024), stated that in 2022, 2.4 million Canadians were affected by heart disease. Automated External Defibrillators play a critical role in managing severe heart conditions such as CAD and myocardial infarction (heart attack). They are used to restore a normal heart rhythm during sudden cardiac arrest, a potential complication of these conditions. These devices can be found in various settings, including public spaces, hospitals, and emergency response kits. Their ability to provide immediate electrical shocks to the heart can significantly improve survival rates and outcomes in cardiac emergencies. In cases of heart disease, where patients may experience irregular heart rhythms or sudden cardiac arrest, automated external defibrillators are essential tools for prompt intervention and treatment.

Rising product developmental activities by regulatory bodies in the region will further boost the market for automated external defibrillators. For example, in January 2023, Avive Solutions, Inc., received the U.S. Food and Drug Administration (FDA) pre-market approval for its Avive AED(TM), a unique Automated External Defibrillator (AED).

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American automated external defibrillators market.

Automated External Defibrillators Market key players:

Some of the key market players operating in the automated external defibrillators market include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

Recent Developmental Activities in the Automated External Defibrillators Market:

  • In October 2023, Medtronic plc, received FDA approval for its Aurora EV-ICD(TM) MRI SureScan(TM) Extravascular Implantable Cardioverter-defibrillator and Epsila EV(TM) MRI SureScan(TM) defibrillation lead. These devices are designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
  • In June 2021, Rapid Response Revival (RRR) earned CE mark certification in Europe for their automated external defibrillator (AED), CellAED.

Key Takeaways from the Automated External Defibrillators Market Report Study

  • Market size analysis for current automated external defibrillators market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the automated external defibrillators market.
  • Various opportunities available for the other competitors in the automated external defibrillators market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current automated external defibrillators market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for automated external defibrillator market growth in the coming future?

Target Audience who can be benefited from this Automated External Defibrillators Market Report Study

  • Automated external defibrillators product providers
  • Research organizations and consulting companies
  • Automated external defibrillators-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in automated external defibrillators
  • Various end-users who want to know more about the automated external defibrillators market and the latest technological developments in the automated external defibrillators market.

Frequently Asked Questions for the Automated External Defibrillators Market:

1. What are Automated External Defibrillators?

Automated external defibrillators are medical devices used to deliver a controlled electric shock to the heart in cases of life-threatening cardiac arrhythmias, such as ventricular fibrillation or pulseless ventricular tachycardia. The purpose of the shock is to reset the heart's electrical activity, allowing it to reestablish a normal rhythm.

2. What is the market for Automated External Defibrillators?

The automated external defibrillators market is estimated to grow at 8.62% CAGR during the forecast period from 2024 to 2030.

3. What are the drivers for the Automated External Defibrillators market?

The automated external defibrillator market is observing substantial market growth primarily owing to the increasing cases of chronic disorders such as cardiovascular diseases including atrial fibrillation and coronary artery disease (CAD), innovative product developmental activities by leading companies, and the rising geriatric population that are expected to escalate the overall growth of the automated external defibrillators market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Automated External Defibrillators market?

Some of the key market players operating in automated external defibrillators include Koninklijke Philips N.V., ZOLL Medical Corporation, BPL Medical Technologies, Stryker, Mediana Co., Ltd, CU Medical System Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd, SCHILLER, Bexen Cardio PLC., Nihon Kohden Corporation, Shenzhen Comen Medical Instruments Co., Ltd., Progetti S.r.l., Abbott, HEARTHERO, Kestra Medical Technologies, Inc., Trivitron Healthcare, F. Amiitalia, Shanghai Huifeng Medical Instrument Co.,Ltd, Metrax GmbH, Meditech Equipment Co .,Ltd, and others.

5. Which region has the highest share in the Automated External Defibrillators market?

North America is expected to dominate the overall automated external defibrillators market during the forecast period from 2024 to 2030. This can be attributed to several factors including high prevalence of coronary artery disease, myocardial infarctions, and other heart conditions, along with associated risk factors for cardiovascular disorders, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the automated external defibrillators market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Automated External Defibrillators Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Automated External Defibrillators Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Automated External Defibrillators Market Key Factors Analysis

  • 5.1. Automated External Defibrillators Market Drivers
    • 5.1.1. Increasing cases of cardiovascular disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Increasing prevalence of lifestyle disorders
    • 5.1.4. Rising geriatric population
  • 5.2. Automated External Defibrillators Market Restraints and Challenges
    • 5.2.1. Electric shock delivered by automated external defibrillators associated with burns or skin damage at the electrode site
  • 5.3. Automated External Defibrillators Market Opportunities
    • 5.3.1. Integration with digital health solutions, such as telemedicine platforms and remote monitoring systems
    • 5.3.2. Application of artificial intelligence and machine learning associated with more accurate diagnosis

6. Automated External Defibrillators Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Automated External Defibrillators Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Wearable
    • 7.1.2. Non-wearable
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Homecare Settings
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.3. India Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Automated External Defibrillators Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Automated External Defibrillators Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Automated External Defibrillators Market Size in USD million (2021-2030)

8. Automated External Defibrillators Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. ZOLL Medical Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. BPL Medical Technologies
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Stryker
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Mediana Co., Ltd
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. CU Medical System Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. SCHILLER
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Bexen Cardio PLC.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Nihon Kohden Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Shenzhen Comen Medical Instruments Co., Ltd.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Progetti S.r.l.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Abbott
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. HEARTHERO
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Kestra Medical Technologies, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Trivitron Healthcare
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. F. Amiitalia
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Shanghai Huifeng Medical Instrument Co.,Ltd
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Metrax GmbH
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Meditech Equipment Co .,Ltd
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Automated External Defibrillators Market in Global (2021-2030)
  • Table 3: Automated External Defibrillators Market in Global by Product Type (2021-2030)
  • Table 4: Automated External Defibrillators Market in Global by End-User (2021-2030)
  • Table 5: Automated External Defibrillators Market in Global by Geography (2021-2030)
  • Table 6: Automated External Defibrillators Market in North America (2021-2030)
  • Table 7: Automated External Defibrillators Market in the United States (2021-2030)
  • Table 8: Automated External Defibrillators Market in Canada (2021-2030)
  • Table 9: Automated External Defibrillators Market in Mexico (2021-2030)
  • Table 10: Automated External Defibrillators Market in Europe (2021-2030)
  • Table 11: Automated External Defibrillators Market in France (2021-2030)
  • Table 12: Automated External Defibrillators Market in Germany (2021-2030)
  • Table 13: Automated External Defibrillators Market in United Kingdom (2021-2030)
  • Table 14: Automated External Defibrillators Market in Italy (2021-2030)
  • Table 15: Automated External Defibrillators Market in Spain (2021-2030)
  • Table 16: Automated External Defibrillators Market in the Rest of Europe (2021-2030)
  • Table 17: Automated External Defibrillators Market in Asia-Pacific (2021-2030)
  • Table 18: Automated External Defibrillators Market in China (2021-2030)
  • Table 19: Automated External Defibrillators Market in Japan (2021-2030)
  • Table 20: Automated External Defibrillators Market in India (2021-2030)
  • Table 21: Automated External Defibrillators Market in Australia (2021-2030)
  • Table 22: Automated External Defibrillators Market in South Korea (2021-2030)
  • Table 23: Automated External Defibrillators Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Automated External Defibrillators Market in the Rest of the World (2021-2030)
  • Table 25: Automated External Defibrillators Market in the Middle East (2021-2030)
  • Table 26: Automated External Defibrillators Market in Africa (2021-2030)
  • Table 27: Automated External Defibrillators Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Automated External Defibrillators Market in Global (2021-2030)
  • Figure 3: Automated External Defibrillators Market in Global by Product Type (2021-2030)
  • Figure 4: Automated External Defibrillators Market in Global by End-User (2021-2030)
  • Figure 5: Automated External Defibrillators Market in Global by Geography (2021-2030)
  • Figure 6: Automated External Defibrillators Market in North America (2021-2030)
  • Figure 7: Automated External Defibrillators Market in the United States (2021-2030)
  • Figure 8: Automated External Defibrillators Market in Canada (2021-2030)
  • Figure 9: Automated External Defibrillators Market in Mexico (2021-2030)
  • Figure 10: Automated External Defibrillators Market in Europe (2021-2030)
  • Figure 11: Automated External Defibrillators Market in France (2021-2030)
  • Figure 12: Automated External Defibrillators Market in Germany (2021-2030)
  • Figure 13: Automated External Defibrillators Market in United Kingdom (2021-2030)
  • Figure 14: Automated External Defibrillators Market in Italy (2021-2030)
  • Figure 15: Automated External Defibrillators Market in Spain (2021-2030)
  • Figure 16: Automated External Defibrillators Market in the Rest of Europe (2021-2030)
  • Figure 17: Automated External Defibrillators Market in Asia-Pacific (2021-2030)
  • Figure 18: Automated External Defibrillators Market in China (2021-2030)
  • Figure 19: Automated External Defibrillators Market in Japan (2021-2030)
  • Figure 20: Automated External Defibrillators Market in India (2021-2030)
  • Figure 21: Automated External Defibrillators Market in Australia (2021-2030)
  • Figure 22: Automated External Defibrillators Market in South Korea (2021-2030)
  • Figure 23: Automated External Defibrillators Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Automated External Defibrillators Market in the Rest of the World (2021-2030)
  • Figure 25: Automated External Defibrillators Market in the Middle East (2021-2030)
  • Figure 26: Automated External Defibrillators Market in Africa (2021-2030)
  • Figure 27: Automated External Defibrillators Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis